A Phase Ib/II Study of Gemcitabine and Docetaxel Plus Pazopanib for the Neoadjuvant (Presurgical) Treatment of Soft-Tissue Sarcoma
[Protocol 11-104] |
Tap, William |
|
A Phase III Study of Doxorubicin Alone or in Combination with TH-302 in Patients with Locally Advanced Inoperable or Metastatic Soft-Tissue Sarcoma
[Protocol 11-203] |
Tap, William |
|
A Phase IB/II Study Evaluating Doxorubicin with or without a IMC-3G3 to Treat Advanced Soft-Tissue Sarcoma
[Protocol 10-156] |
Tap, William |
|
A Phase I Study of PLX3397 in Patients with Advanced Solid Tumors
[Protocol 12-156] |
Tap, William |
|
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women with Ovarian Cancer
[Protocol 11-164] |
Tew, William |
- Geriatrics
- Ovarian Cancer
|
A Phase II Study of MLN8237 (Alisertib) with Paclitaxel versus Paclitaxel Alone in Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-100] |
Tew, William |
|
Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
[Protocol 12-104] |
Tew, William |
- Geriatrics
- Ovarian Cancer
|
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
[Protocol 12-089] |
Tew, William |
|
Prospective Ascertainment for Late Effects Among Cancer Survivors
[Protocol 12-143] |
Tonorezos, Emily |
|
A Phase II Study of Dose-Dense Doxorubicin and Cyclophosphamide followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer
[Protocol 10-190] |
Traina, Tiffany |
|
A Phase I Study of Enzalutamide (MDV3100) in Patients with Previously Treated Metastatic Breast Cancer
[Protocol 12-155] |
Traina, Tiffany |
|
A Phase II Study of Abiraterone, Exemestane, or Both in Postmenopausal Women with ER-Positive Metastatic Breast Cancer
[Protocol 12-140] |
Traina, Tiffany |
|
A Phase II Study of Abraxane with or without Tigatuzumab in Patients with Metastatic Triple-Negative Breast Cancer
[Protocol 11-082] |
Traina, Tiffany |
|
A Phase I Trial of NECTAR: Nelarabine, Etoposide, and Cyclophosphamide in Children with T-Cell Acute Lymphoblastic Leukemia
[Protocol 11-119] |
Trippett, Tanya |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase I/II Clinical Study of Vorinostat Plus Etoposide in Pediatric Patients with Refractory Solid Tumors
[Protocol 10-096] |
Trippett, Tanya |
|
A Phase I Study of Blinatumomab in Children and Adolescents with Relapsed/Refractory Acute Lymphoblastic Leukemia
[Protocol 12-044] |
Trippett, Tanya |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase I Study of AC220 for Children with Relapsed or Refractory Acute Leukemias
[Protocol 12-141] |
Trippett, Tanya |
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelogenous Leukemia
|
A Phase II Study of Sorafenib in Children and Young Adults with Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, or Papillary Thyroid Cancer
[Protocol 12-139] |
Trippett, Tanya |
- Hepatobiliary
- Kidney Cancer
- Sarcomas
- Thyroid Cancer
|
A Phase II Study of Cyclophosphamide, Topotecan, and Bevacizumab in Patients with Relapsed or Refractory Ewing's Sarcoma and Neuroblastoma
[Protocol 11-183] |
Trippett, Tanya |
- Neuroblastoma
- Primary Bone
- Sarcomas
- Ewing's Sarcoma
- Soft Tissue Sarcoma
|
A Phase I/II Study of Brentuximab (SGN-35) in Pediatric Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma or Hodgkin Lymphoma
[Protocol 11-210] |
Trippett, Tanya |
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
|
